4//SEC Filing
Lizak Carol R. 4
Accession 0001104659-24-063897
CIK 0001585608other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 5:02 PM ET
Size
9.1 KB
Accession
0001104659-24-063897
Insider Transaction Report
Form 4
Lizak Carol R.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-05-17+431→ 1,042 total - Exercise/Conversion
Restricted stock units
2024-05-17−431→ 431 total→ Common Stock (431 underlying)
Holdings
- 106(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On January 23, 2023, the issuer effected a 75-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "January 2023 Reverse Stock Split). Upon effectiveness of the January 2023 Reverse Stock Split, every 75 shares of voting common stock was automatically converted into one share of voting common stock.
- [F3]The restricted stock units were originally approved by the issuer's board of directors on March 28, 2022 and previously reported as covering 97,025 shares, but were adjusted to reflect the January 2023 Reverse Stock Split. The restricted stock units vest in three equal annual installments beginning on May 17, 2023. Vested shares will be delivered to the reporting person on the vesting date provided in the grant notice.
- [F4]Securities held directly by the Peter & Carol Lizak Revocable Trust. Ms. Lizak, by virtue of her position as a co-trustee and beneficiary of such trust and her sharing of voting and investment control over the securities held by the trust with her spouse, may be deemed to beneficially own the securities held by the Peter & Carol Lizak Trust for purposes of Section 16.
Documents
Issuer
Jaguar Health, Inc.
CIK 0001585608
Entity typeother
Related Parties
1- filerCIK 0001785794
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 5:02 PM ET
- Size
- 9.1 KB